Mexico
11 Vaccines Approved for Use in Mexico
Protein Subunit
Center for Genetic Engineering and Biotechnology (CIGB)
Abdala
Approved in 6 countries
5 trials in 1 country
Approval Source: abcnews.go.com
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: nytimes.com
Non Replicating Viral Vector
Non Replicating Viral Vector
Gamaleya
Sputnik V
Approved in 74 countries
25 trials in 8 countries
Approval Source: coronavirus.gob.mx
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: gob.mx
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: coronavirus.gob.mx
Inactivated
Bharat Biotech
Covaxin
Approved in 14 countries
16 trials in 2 countries
Approval Source: timesofindia.indiatimes.com
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Approval Source: gob.mx
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
42 trials in 10 countries
Approval Source: coronavirus.gob.mx
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: gob.mx
13 in Clinical Trials in Mexico
Protein Subunit
Novavax
Nuvaxovid
Approved in 40 countries
22 trials in 14 countries
DNA
Inovio
INO-4800
10 trials in 9 countries
RNA
Walvax
mRNA
4 trials in 3 countries
Non Replicating Viral Vector
CanSino
Ad5-nCoV-IH
Approved in 1 country
5 trials in 4 countries
Non Replicating Viral Vector
CanSino
Convidecia
Approved in 10 countries
14 trials in 6 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Inactivated
Laboratorio Avi-Mex
Recombinant NDV Vectored Vaccine
2 trials in 1 country
Protein Subunit
West China Hospital
Recombinant (Sf9 cell)
9 trials in 5 countries
RNA
Moderna
Spikevax
Approved in 88 countries
70 trials in 24 countries
RNA
Walvax
AWcorna
Approved in 1 country
4 trials in 3 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
1 Vaccines with Trials in Mexico are No Longer Progressing
RNA
Curevac
CVnCoV
9 trials in 12 countries